DEA Greenlights PTSD Cannabis Study

DEA Greenlights PTSD Cannabis Study


 - The Washington Times - Friday, April 22, 2016

The U.S. Drug Enforcement Agency agreed for the first time ever this week to let researchers conduct clinical trials with marijuana to examine the potential benefits of using the plant to treat post-traumatic stress disorder.


A California-based nonprofit research group, the Multidisciplinary Approach to Psychedelic Studies (MAPS), announced on Thursday that the DEA will allow its scientists to conduct a double-blind, placebo-controlled study specifically designed to determine the potential benefits of medicinal marijuana with regards to treating PTSD.


Read the full article here:

http://www.washingtontimes.com/news/2016/apr/22/dea-greenlights-marijuana-study-to-measure-pots-ef/


Older Post Newer Post

Join our e-mail list to stay informed with River updates and industry news.

Please verify your age